drugmaker

Novo Nordisk latest drugmaker to drop gender goals in US
Novo Nordisk latest drugmaker to drop gender goals in US
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiativesPublished Wed, May 7, 2025 · 06:55 PM[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday...
Obesity drugmaker Novo Nordisk posts strong profit
Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov 6) strong third-quarter earnings despite being held back by...
Drugmaker AstraZeneca’s market value soars past £200 billion
Drugmaker AstraZeneca’s market value soars past £200 billion
ASTRAZENECA’S market value surged above £200 billion (S$338 billion) for the first time after a big bet on cancer drugs helped drive a rally in the shares. Shares climbed as...
GSK plunges as drugmaker must face Zantac cases in Delaware
GSK plunges as drugmaker must face Zantac cases in Delaware
Citi estimates Zantac settlement costs at US$3 billionGSK shares plunged in the wake of a court ruling that the UK drugmaker, alongside others including Sanofi, must face trials over...
Asahi Kasei to buy Swedish drugmaker Calliditas for US.1 billion
Asahi Kasei to buy Swedish drugmaker Calliditas for US$1.1 billion
Japan’s Asahi Kasei said on Tuesday (May 28) it offered to acquire Calliditas Therapeutics for about US$1.1 billion as part of a plan to become a global drug company.The...
Drugmaker Abbott India posts Q4 profit rise on higher sales
Drugmaker Abbott India posts Q4 profit rise on higher sales
Indian drugmaker Abbott India reported a 24 per cent rise in fourth-quarter profit on Thursday (May 9), as strong sales outpaced the impact of government pricing caps on certain...
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
Japan’s Takeda Pharmaceutical said full-year earnings slumped by more than half as the company focused on rebuilding its drug pipeline to make up for the loss of patent protection...
Obesity drugmaker Novo Nordisk posts strong profit
Weight-loss drugmaker Novo Nordisk’s profits soar further
Danish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday (May 2) thanks to the popularity of anti-diabetes and weight-loss drugs Ozempic and Wegovy, which have made it...
Lilly’s US.5 billion German plant will boost obesity-drug supply
Lilly’s US$2.5 billion German plant will boost obesity-drug supply
ELI Lilly kicked off construction of a new plant to boost the production of its wildly popular weight-loss drugs, which have yet to gain a foothold in Europe.The factory...
China’s first biosimilar Ozempic drug applies for approval
China’s first biosimilar Ozempic drug applies for approval
A CHINESE drugmaker has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for its approval. Hangzhou Jiuyuan Gene Engineering said on Wednesday (Apr 3) in...